Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0790
+0.0020 (2.60%)
May 18, 2026, 4:11 PM AEST
Genetic Signatures Market Cap
Genetic Signatures has a market cap or net worth of 17.94 million as of May 18, 2026. Its market cap has decreased by -79.48% in one year.
Market Cap
17.94M
Enterprise Value
-11.37M
Revenue
19.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since March 31, 2015, Genetic Signatures's market cap has decreased from 35.38M to 17.94M, a decrease of -49.28%. That is a compound annual growth rate of -5.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 17.94M | -68.40% |
| Dec 31, 2025 | 56.79M | -60.32% |
| Dec 31, 2024 | 143.10M | 99.47% |
| Dec 29, 2023 | 71.74M | -43.15% |
| Dec 30, 2022 | 126.20M | -50.73% |
| Dec 31, 2021 | 256.15M | -10.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 353.56M |
| Monash IVF Group | 284.43M |
| Healius | 250.52M |
| Rhythm Biosciences | 50.43M |
| Cryosite | 48.81M |
| Microba Life Sciences | 46.89M |
| INOVIQ | 45.05M |
| BCAL Diagnostics | 30.60M |